Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epidemiology of hepatocellular carcinoma: consider the population.

Literature DB >> 23632345

Epidemiology of hepatocellular carcinoma: consider the population.

Abstract

Hepatocellular carcinoma (HCC) is increasing in incidence and has a very high fatality rate. Cirrhosis due to chronic hepatitis B or hepatitis C is the leading risk factor for HCC. Global epidemiology of HCC is determined by the prevalence of dominant viral hepatitis and the age it is acquired in the underlying population. Upcoming risk factors include obesity, diabetes, and related nonalcoholic fatty liver disease. This review discusses the latest trends of HCC globally and in the United States. It also provides an evidence-based commentary on the risk factors and lists some of the preventive measures to reduce the incidence of HCC.

Entities: Chemical Disease Gene Species

Mesh：

Year: 2013 PMID： 23632345 PMCID： PMC3683119 DOI： 10.1097/MCG.0b013e3182872f29

Source DB: PubMed Journal: J Clin Gastroenterol ISSN： 0192-0790 Impact factor: 3.062

56 in total

1. Tumour necrosis factor-alpha polymorphisms and hepatocellular carcinoma: a meta-analysis.

Authors: H Qin; B Liu; T Shi; Y Liu; Y Sun; Y Ma
Journal: J Int Med Res Date: 2010 May-Jun Impact factor: 1.671

2. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.

Authors: Hashem B El-Serag; Jennifer R Kramer; G John Chen; Zhigang Duan; Peter A Richardson; Jessica A Davila
Journal: Gut Date: 2011-01-21 Impact factor: 23.059

3. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.

Authors: Tania M Welzel; Barry I Graubard; Stefan Zeuzem; Hashem B El-Serag; Jessica A Davila; Katherine A McGlynn
Journal: Hepatology Date: 2011-06-30 Impact factor: 17.425

4. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).

Authors: Franco Trevisani; Stefania De Notariis; Gianludovico Rapaccini; Fabio Farinati; Luisa Benvegnù; Marco Zoli; Gian Luca Grazi; Poggio Paolo Del; NolfoMariaAnna Di; Mauro Bernardi
Journal: Am J Gastroenterol Date: 2002-03 Impact factor: 10.864

5. The global health burden of infection-associated cancers in the year 2002.

Authors: Donald Maxwell Parkin
Journal: Int J Cancer Date: 2006-06-15 Impact factor: 7.396

6. Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients.

Authors: Yasuji Arase; Mariko Kobayashi; Fumitaka Suzuki; Yoshiyuki Suzuki; Yusuke Kawamura; Norio Akuta; Norihiro Imai; Masahiro Kobayashi; Hitomi Sezaki; Naoki Matsumoto; Satoshi Saito; Tetsuya Hosaka; Kenji Ikeda; Hiromitsu Kumada; Yuki Ohmoto; Kazuhisa Amakawa; Shiun Dong Hsieh; Kyoko Ogawa; Maho Tanabe; Hiroshi Tsuji; Tetsuro Kobayashi
Journal: Hepatol Res Date: 2011-12-19 Impact factor: 4.288

7. Hepatocellular carcinoma in Italian patients with cirrhosis.

Authors: M Colombo; R de Franchis; E Del Ninno; A Sangiovanni; C De Fazio; M Tommasini; M F Donato; A Piva; V Di Carlo; N Dioguardi
Journal: N Engl J Med Date: 1991-09-05 Impact factor: 91.245

8. Epidemiology of hepatocellular carcinoma in Hispanics in the United States.

Authors: Hashem B El-Serag; Melvin Lau; Karl Eschbach; Jessica Davila; James Goodwin
Journal: Arch Intern Med Date: 2007-10-08

9. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.

Authors: G S Qian; R K Ross; M C Yu; J M Yuan; Y T Gao; B E Henderson; G N Wogan; J D Groopman
Journal: Cancer Epidemiol Biomarkers Prev Date: 1994 Jan-Feb Impact factor: 4.254

10. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China.

Authors: J Shi; L Zhu; S Liu; W-F Xie
Journal: Br J Cancer Date: 2005-02-14 Impact factor: 7.640

451 in total

Review 1. Virus-based nanoparticles as platform technologies for modern vaccines.

Authors: Karin L Lee; Richard M Twyman; Steven Fiering; Nicole F Steinmetz
Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol Date: 2016-01-19

Review 2. Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development.

Authors: Juan Wang; Guixiang Tai
Journal: Target Oncol Date: 2016-12 Impact factor: 4.493

3. An indeterminate nodule in the cirrhotic liver discovered by surveillance imaging is a prelude to malignancy.

Authors: Eliza W Beal; Scott Albert; Megan McNally; Lawrence A Shirley; James Hanje; Anthony J Michaels; Sylvester M Black; Mark Bloomston; Carl R Schmidt
Journal: J Surg Oncol Date: 2014-08-25 Impact factor: 3.454

Review 4. Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis.

Authors: Kerstin Schütte; Christian Schulz; Alexander Link; Peter Malfertheiner
Journal: World J Hepatol Date: 2015-02-27

5. Effect of Derris scandens extract on a human hepatocellular carcinoma cell line.

Authors: Duanghathai Kuljittichanok; Penchatr Diskul-Na-Ayudthaya; Churat Weeraphan; Daranee Chokchaichamnankit; Khajeelak Chiablaem; Kriengsak Lirdprapamongkol; Jisnuson Svasti; Chantragan Srisomsap
Journal: Oncol Lett Date: 2018-05-29 Impact factor: 2.967

10. Bromodomain and Extraterminal (BET) Proteins Regulate Hepatocyte Proliferation in Hepatocyte-Driven Liver Regeneration.

Authors: Jacquelyn O Russell; Sungjin Ko; Harvinder S Saggi; Sucha Singh; Minakshi Poddar; Donghun Shin; Satdarshan P Monga
Journal: Am J Pathol Date: 2018-03-12 Impact factor: 4.307